Patterns of progression in oligometastatic hormone receptor positive breast cancer after first-line systemic treatment at the metastatic stage

被引：0
|
作者：
Lacaze, Jean Louis
De Maio, Eleonora
Chaltiel, Leonor
Cabarrou, Bastien
Mounat, Thibaut Cassou
Chira, Ciprian
Glemarec, Gauthier
Massabeau, Carole
Nicolai, Vincent
Selmes, Gabrielle
机构：
[1] IUCT Oncopole, Inst Claudius Regaud, Toulouse, France
[2] IUCT Oncopole, Toulouse, France
[3] IUCT Oncopole, Inst Claudius Regaud, Dept Chirurg Oncol, Toulouse, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13054
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Fulvestrant (F) as first-line palliative treatment for hormone receptor (HR)- positive metastatic breast cancer
    Bartsch, R.
    Wenzel, C.
    Ziebermayr, R.
    Bago-Horvath, Z.
    Pluschnig, U.
    Dubsky, P. C.
    Rudas, M.
    Gnant, M.
    Zielinski, C.
    Steger, G. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Taxanes as a First-Line Systemic Treatment in Metastatic Breast Cancer
    Urquhart, Laura M.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (01) : 15 - 21
  • [3] Navigating Systemic Therapeutic Options for First-Line Metastatic Hormone Receptor-Positive, ERBB2-Negative Breast Cancer Treatment
    Martei, Yehoda M.
    Clark, Amy S.
    JAMA NETWORK OPEN, 2022, 5 (04)
  • [4] Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea
    Beom, Seung Hoon
    Oh, Jisu
    Kim, Tae-Yong
    Lee, Kyung-Hun
    Yang, Yaewon
    Suh, Koung Jin
    Moon, Hyeong-Gon
    Han, Sae-Won
    Oh, Do-Youn
    Han, Wonshik
    Kim, Tae-You
    Noh, Dong-Young
    Im, Seock-Ah
    CANCER RESEARCH AND TREATMENT, 2017, 49 (02): : 454 - 463
  • [5] First-Line Treatment Patterns and Clinical Outcomes in Patients With HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer From registHER
    Tripathy, Debu
    Kaufman, Peter A.
    Brufsky, Adam M.
    Mayer, Musa
    Yood, Marianne Ulcickas
    Yoo, Bongin
    Quah, Cheng
    Yardley, Denise
    Rugo, Hope S.
    ONCOLOGIST, 2013, 18 (05): : 501 - 510
  • [6] Maintenance hormone therapy with letrozole after first-line chemotherapy in postmenopausal patients with hormone receptor-positive metastatic breast cancer
    Borrego, M. Ruiz
    De la Haba, J.
    Morales, S.
    Ramos, M.
    Velasco, A.
    Mendez, M.
    Carabantes, F.
    Barnadas, A.
    Garcia, M.
    Moreno, J. A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 117 - 117
  • [7] Maintenance hormone therapy with letrozole after first-line chemotherapy in postmenopausal patients with hormone receptor-positive metastatic breast cancer
    Ruiz, Manuel
    De la Haba, Juan
    Morales, Serafin
    Ramos, Manuel
    Velasco, Amlia
    Mendez, Miguel
    Carabantes, Francisco
    Barnadas, Agusti
    Garcia, Maria
    Moreno, Jose A.
    ANNALS OF ONCOLOGY, 2004, 15 : 35 - 35
  • [8] Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer
    Al Mahmasani, Layal
    Amhaz, Ghid
    Abou Zeidane, Reine
    Chamseddine, Nathalie
    Hatab, Taha
    Sabbagh, Saad
    Charafeddine, Maya
    Assi, Hazem I.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Hormone therapy versus chemotherapy as first-line treatment for estrogen receptor-positive metastatic breast cancer (MBC) patients
    Chang, T. Y.
    Lin, C.
    Lu, Y.
    Kuo, S. H.
    Huang, S.
    Huang, C.
    Cheng, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] First-line treatment of metastatic breast cancer
    Trudeau, ME
    ANTI-CANCER DRUGS, 1996, 7 : 9 - 12
12345